BHCBausch Health Companies Inc.
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Choppy, but holding above its 200-day average. Price is +3% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 9, 2026; selling is often routine (taxes, diversification).
Lightly shorted, settled Sep 30, 2026, about a week of normal trading to cover. Down 2.6% since the previous count, up from 2.0% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How BHC is trading
Bausch Health Companies Inc. is −10% over the past year while the S&P 500 is +18%: 29 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +2.9%
vs 200-day average · close to trend
- RSI (14)
- 67
RSI (14) · neutral
- Below its 52-week high
- 24%
Below its 52-week high
Details›
- Last close2026-10-09
- $6.04
- 1 monthS&P 500 +2.7%
- −0.49%
- 1 yearS&P 500 +18%
- −10%
- 5 yearsS&P 500 +88%
- −79%
- vs 50-day average$6.12
- −1.3%
- 52-week high
- $7.90
- 52-week low
- $4.44
- Annualised volatility
- 64%
| Year | Return |
|---|---|
| 2026 (year to date) | −13% |
| 2025 | −14% |
| 2024 | +0.50% |
| 2023 | +28% |
| 2022 | −77% |
| 2021 | +33% |
| 2020 | −30% |
| 2019 | +62% |
| 2018 | −11% |
| 2017 | +43% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | +1.5% |
| Feb | 10 | 6 of 10 | +3.5% |
| Mar | 10 | 3 of 10 | −7.8% |
| Apr | 10 | 4 of 10 | −4.6% |
| May | 10 | 4 of 10 | −4.0% |
| Jun | 10 | 5 of 10 | +9.6% |
| Jul | 11 | 2 of 11 | −6.2% |
| Aug | 11 | 5 of 11 | +7.0% |
| Sep | 11 | 5 of 11 | +2.2% |
| Oct | 11 | 6 of 11 | −3.0% |
| Nov | 10 | 6 of 10 | +4.4% |
| Dec | 10 | 6 of 10 | +3.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #13 of 41 by RyuScore